Development and Validation of UV Spectrophotometric Method for Determination of Trimetazidine Dihydrochloride in Modified Release Tablet Formulation

K. Chomaničová,Š. Husár,K. Maráková,M. Sýkorová

DOI: https://doi.org/10.1007/s11094-022-02673-4

2022-07-10

Pharmaceutical Chemistry Journal

Abstract:The UV spectrophotometric analysis is often preferred for quality control of pharmaceuticals in ordinary laboratories due to its broad-range availability and suitability. In this work, we have developed and validated a simple, accurate and precise UV spectrophotometric method to quantify trimetazidine (TMZ) dihydrochloride in modified release tablet dosage form. Methanol was selected as the best solvent and the maximum absorption for drug analysis was detected at a wavelength of 270 nm. The proposed method proved to be specific and its linearity was proved in a concentration range of 105–315 μg/mL with a determination coefficient of 0.999. The %RSD values obtained during precision assay (intra-day RSD = 0.68%, inter-day RSD = 0.42 – 1.03%) indicated good repeatability and reliability of analyses. The accuracy testing performed as recovery studies showed good results as well. The limit of detection and limit of quantitation were found to be 2.21 and 6.70 μg/mL, respectively. The robustness and ruggedness tests were performed and showed that the developed method is adequate for TMZ quantitation. The result of TMZ assay determination in modified release tablets was 90.08% (RSD = 0.83 %). Nevertheless, the proposed method can be used for the determination of TMZ in modified release tablets without time consuming preparation of a sample and with low use of polluting reagents and a shorter analysis time, as reliable and more economical alternative to the potentiometric titration method according to European Pharmacopoeia.

pharmacology & pharmacy,chemistry, medicinal